Join Cerba Research at the World Vaccine Congress Europe 2024, where we will showcase our extensive expertise in laboratory services for vaccine research and development.
Marta Murreddu will present groundbreaking “Assay Development Advancements in Human Metapneumovirus (hMPV) Vaccine Research” highlighting our commitment to accelerating innovation in immunology and infectious diseases.
When?
Wednesday 30 October 11:10-11:25 hrs
Marc van Pruijssen will present on “Compliance in Supply Chain & Logistics Operations: Make or Break Your Clinical Trial“ addressing the evolving regulations and the need to keep abreast of changes in laboratory logistics and kit management.
When?
Thursday 31 October
13:45-14:45 hrs
Visit us at booth 58 to learn how our specialized services and global central laboratory capability will support your vaccine development journey from early discovery to late phase.
Let’s connect and explore new possibilities together!
Meet our speakers
Marc van Pruijssen
General Manager Clinical Trial Services & Logistics Management Senior Vice-President Global Logistics and CTOS
Since October 2023, Marc Van Pruijssen has served as Cerba Research’s General Manager of Clinical Trial Services & Logistics Management.
Since April 2020, he has been the VP of marketing and a member of the board of Council of Supply Chain Management Professionals (CSCMP) Benelux. Prior to this, Marc was a leader at Viroclinics Biosciences and Viroclinics Xellerate.
For more than 10 years with Amway, Marc held roles in a number of areas, including Director of Supply Chain Development & Innovation. He began his professional career at Lamb Weston, as a Total Quality Management Specialist.
Marc holds a master’s degree in transport and logistics management from TIAS School for Business and Society, as well as a master of science in management & organizational sciences from Tilburg University.
Marta Murreddu
Business Development Manager
Marta G. Murreddu is a seasoned project management professional in virology clinical research; successfully managing clinical trials, client communications, and ensuring adherence to timelines and budgets.
From 2021 to 2023, she led Clinical Virology Services at Viroclinics (acquired by Cerba Research), where she managed teams, handled Phase 1–3 trials, and contributed to the Biosafety Committee. Additionally, she served as Study Director at Xplore, supervising pre-clinical biotechnical projects.
Marta holds a PhD in Microbiology from Università Cattolica and a Master’s in Biology from Università degli Studi di Cagliari. Her postdoctoral work, funded by Roche at Georgetown, focused on hepatitis B research, and she managed a BSL3 lab at Virginia Tech.
She has published extensively on antiviral effects and vaccine stability and holds certifications in Project Management and Lean Six Sigma. Her strong leadership and strategic skills contribute significantly to global health initiatives.
